Hospital/Health-System Pharmacy
First orally inhaled drug available for agitation in schizophrenia, bipolar disorder
March 06, 2014By Julia Talsma Content Channel Director
Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.Pharmacy groups support expansion of MTM services in Medicare proposal
March 06, 2014By Julia Talsma Content Channel Director
Pharmacy groups, representing more than 100,000 pharmacists in different pharmacy practice settings, have written to CMS Administrator Marilyn B. Tavenner to express their support for the expansion of medication therapy management (MTM) services to Medicare Part D beneficiaries in the CMS proposal released in early January.Stroke prevention in the elderly may be excessive, researcher says
March 03, 2014By Tracey Walker Contributing Editor
Patients more than 80 years old are being “over-treated” for stroke prevention with statins and antihypertensive drugs, and doctors need to actively rethink their priorities and beliefs about stroke prevention, according to a new study published in Evidence Based Medicine.Advertisement
FDA panels vote against OTC Primatene HFA inhaler
March 03, 2014By Julia Talsma Content Channel Director
FDA advisors decided against recommending over-the-counter (OTC) marketing approval of Primatene HFA inhaler (Armstrong Pharmaceuticals) for the temporary relief of mild symptoms of intermittent asthma in patients 12 years and older, at last week’s joint meeting of the FDA’s Nonprescription Drugs Advisory Committee and the Pulmonary-Allergy Drugs Advisory Committee.- 1
- 2